Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019

  02 January 2020

Lithuania reported an outbreak of carbapenem-resistant, and for some cases, colistin-resistant, Enterobacterales in November 2019. Between 1 February and 26 November 2019, 199 cases were detected, including cases with infection as well as carriage. The majority of cases (186 cases) occurred in one single hospital (Hospital 1). Most of the carbapenem-resistant Enterobacterales (CRE) isolates were Klebsiella pneumoniae (93%), followed by Escherichia coli. In all isolates, carbapenem resistance was mediated by a Klebsiella pneumoniae carbapenemase (KPC) enzyme.

Further reading: ECDC
Author(s): ECDC
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!